Cansu Ozbayer1, Hulyam Kurt2, Aysegul Bayramoglu3, Hasan Veysi Gunes2, Muzaffer Metintas4, İrfan Degirmenci2, Kevser Setenay Oner5. 1. Department of Medical Biology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey. c.ozbayer@gmail.com. 2. Department of Medical Biology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey. 3. Department of Biology, Faculty of Arts and Sciences, Artvin Coruh University, Artvin, Turkey. 4. Department of Chest Diseases, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey. 5. Department of Biostatistics, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
Abstract
BACKGROUND AND AIM: NOD1/CARD4 and NOD2/CARD15 are members of the Nod-like receptor (NLR) family, and they contain a caspase recruitment domain (CARD). NLRs are located in the cytosol where they bind bacterial and viral ligands and play a key role in the innate and adaptive immune response, apoptosis, autophagy, and reactive oxygen species generation. NLR gene polymorphisms may shift the balance between pro- and anti-inflammatory cytokines and modulate the risk of infection, chronic inflammation, and cancer. NOD1/CARD4 and NOD2/CARD15 gene polymorphisms may also be associated with altered risks for many cancer types. The aim of our study was to evaluate the potential associations between lung cancer and NOD1/CARD4 and NOD2/CARD15 polymorphisms. METHOD: The NOD1/CARD4 (rs5743336) and NOD2/CARD15 (rs2066847) SNPs were analyzed by PCR restriction fragment-length polymorphism analysis (PCR-RFLP) in 260 subjects (lung cancer patients: n = 160; healthy controls: n = 100) of Turkish origin. PCR products were digested with AvaI for rs5743336 and ApaI for rs2066847 and then visualized. RESULTS: Comparisons of the genotypes between control and lung cancer patients were performed by Chi-square tests. We found a significant difference in the genotypic distribution of the rs5743336 variant of NOD1/CARD4 between lung cancer patients and controls (p = 0.010, χ (2) = 9.220). However, we did not identify any statistically significant difference for the p.Leu1007fsX1008 (rs2066847) genotype of NOD2/CARD15 between groups (p > 0.05). CONCLUSION: According to our data, the rs5743336 variant of the NOD1/CARD4 gene may influence the diagnosis and treatment of lung cancer, whereas the rs2066847 variant of the NOD2/CARD15 gene is not associated with lung cancer risk in the Turkish population.
BACKGROUND AND AIM: NOD1/CARD4 and NOD2/CARD15 are members of the Nod-like receptor (NLR) family, and they contain a caspase recruitment domain (CARD). NLRs are located in the cytosol where they bind bacterial and viral ligands and play a key role in the innate and adaptive immune response, apoptosis, autophagy, and reactive oxygen species generation. NLR gene polymorphisms may shift the balance between pro- and anti-inflammatory cytokines and modulate the risk of infection, chronic inflammation, and cancer. NOD1/CARD4 and NOD2/CARD15 gene polymorphisms may also be associated with altered risks for many cancer types. The aim of our study was to evaluate the potential associations between lung cancer and NOD1/CARD4 and NOD2/CARD15 polymorphisms. METHOD: The NOD1/CARD4 (rs5743336) and NOD2/CARD15 (rs2066847) SNPs were analyzed by PCR restriction fragment-length polymorphism analysis (PCR-RFLP) in 260 subjects (lung cancerpatients: n = 160; healthy controls: n = 100) of Turkish origin. PCR products were digested with AvaI for rs5743336 and ApaI for rs2066847 and then visualized. RESULTS: Comparisons of the genotypes between control and lung cancerpatients were performed by Chi-square tests. We found a significant difference in the genotypic distribution of the rs5743336 variant of NOD1/CARD4 between lung cancerpatients and controls (p = 0.010, χ (2) = 9.220). However, we did not identify any statistically significant difference for the p.Leu1007fsX1008 (rs2066847) genotype of NOD2/CARD15 between groups (p > 0.05). CONCLUSION: According to our data, the rs5743336 variant of the NOD1/CARD4 gene may influence the diagnosis and treatment of lung cancer, whereas the rs2066847 variant of the NOD2/CARD15 gene is not associated with lung cancer risk in the Turkish population.
Authors: Matthew S Forrest; Christine F Skibola; Tracy J Lightfoot; Paige M Bracci; Eleanor V Willett; Martyn T Smith; Elizabeth A Holly; Eve Roman Journal: Br J Haematol Date: 2006-06-01 Impact factor: 6.998
Authors: T Molnar; P Hofner; F Nagy; P L Lakatos; S Fischer; L Lakatos; A Kovacs; I Altorjay; M Papp; K Palatka; P Demeter; Z Tulassay; T Nyari; P Miheller; J Papp; Y Mandi; J Lonovics Journal: Dig Liver Dis Date: 2007-10-26 Impact factor: 4.088
Authors: Dermot P B McGovern; Pirro Hysi; Tariq Ahmad; David A van Heel; Miriam F Moffatt; Alisoun Carey; William O C Cookson; Derek P Jewell Journal: Hum Mol Genet Date: 2005-03-24 Impact factor: 6.150
Authors: Jochen Hampe; Andre Franke; Philip Rosenstiel; Andreas Till; Markus Teuber; Klaus Huse; Mario Albrecht; Gabriele Mayr; Francisco M De La Vega; Jason Briggs; Simone Günther; Natalie J Prescott; Clive M Onnie; Robert Häsler; Bence Sipos; Ulrich R Fölsch; Thomas Lengauer; Matthias Platzer; Christopher G Mathew; Michael Krawczak; Stefan Schreiber Journal: Nat Genet Date: 2006-12-31 Impact factor: 38.330
Authors: Juozas Kupcinskas; Thomas Wex; Jan Bornschein; Michael Selgrad; Marcis Leja; Elona Juozaityte; Gediminas Kiudelis; Laimas Jonaitis; Peter Malfertheiner Journal: BMC Med Genet Date: 2011-08-24 Impact factor: 2.103
Authors: Henry Y Jiang; Sara Najmeh; Guy Martel; Elyse MacFadden-Murphy; Raquel Farias; Paul Savage; Arielle Leone; Lucie Roussel; Jonathan Cools-Lartigue; Stephen Gowing; Julie Berube; Betty Giannias; France Bourdeau; Carlos H F Chan; Jonathan D Spicer; Rebecca McClure; Morag Park; Simon Rousseau; Lorenzo E Ferri Journal: Protein Cell Date: 2020-01-19 Impact factor: 14.870